.png)
Nagourney Cancer Institute: 20-year Experience in 10,000 Patients
At the 2023 American Association for Cancer Research meeting in Orlando, we reported results of ex vivo analysis of programmed cell death.
top of page
TestigProcess
What is Functional Profiling?
We perform Functional Profiling, a laboratory technique that measures how cancer cells respond when exposed to a variety of drugs and drug combinations.
Functional Profiling is more powerful than genomic testing that most centers offer.
This approach reduces the guesswork from drug selection to find the most effective, least toxic options. Results only take 7 days.
You and your doctor can then use this information to guide your treatment.
OUR TESTING PROCESS
Ex Vivo Best Regimen Provides A 2.04 Fold Higher Response and 1.44 Fold Higher One-Year Survival*
*(Apfel C, et al . Proc Amer. Soc. Clin. Oncol. 2013)
Step 1
Sterile Surgical Specimen
Surgical Specimen is collected and transported overnight to our lab.
Step 2
Cancer Cell Natural Explants* Isolated
Step 3
Explants* Exposed To Drugs and Combinations: Never Grown or Sub-cultured
We do not use 3D organoids or anything except the patient's own cells to test.
Step 4
Explants* Incubated to Allow
Drugs to Take Effect
Step 5
Tumor Explant* Survival Analyzed to Score Programmed Cell Death
Step 6
Explant* Results Compared
With Over Ten Thousand
Patient Studies in our Database
This process reduces the guesswork and gives you the information you and your oncologist need to help you make a truly informed decision about your treatment with the best available data.
* An Explant is a portion of tumor that has been maintained in tissue culture without disrupting the architecture or structure of the cancer cell micro-environment. Unlike cultured “3-D Organoids” Explants are never grown or amplified. This preserves their validity for clinical response prediction.
Dr. Robert Nagourney is an internationally recognized pioneer in cancer research and personalized cancer treatment.
With more than 20 years of experience in human tumor primary culture analyses, Dr. Nagourney has authored more than 100 manuscripts and abstracts including publications in the Journal of Clinical Oncology, Gynecologic Oncology, and the Journal of the National Cancer Institute.
Over the past 20+ years, Dr. Nagourney and his team at the Nagourney Cancer Institute have developed a laboratory technique, functional profiling, that measures how cancer cells respond when they are exposed to a wide variety of drugs and drug combinations.
By using this approach, the Nagourney team can determine the best drugs for each patient before they receive them. This reduces the guesswork in selecting the right drug treatment for you and is why our analysis is more powerful than genomic testing offered by most centers.
Nagourney Cancer Institute
We analyze your living cancer cells to find out the drugs, combinations, and sequences that are most effective for you. This reduces the guesswork in selecting your cancer treatment by measuring how your cancer cells will respond to drugs before you receive treatment.
This helps select the most effective and least toxic drug regimen for your cancer.
Why Nagourney Cancer Institute?
Accomplished cancer research and testing facility with a fully accredited federal and state-licensed laboratory. State-of-the-art personalized cancer testing which helps select the most effective and least toxic cancer treatment.
We also work with pharmaceutical and biotechnology firms to streamline their research and development process for bringing new compounds to market.
Cancer Patient Success Stories
John Stamos
"He is a tireless man who has really devoted his life to helping people"
Maria Lewis
"You would never know that I was once a cancer patient by looking at me now."
Dr. Robert Nagourney
bottom of page